Learn More
Human CD37 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB4625
Description
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with NS0 cells transfected with human CD37 (Accession Q96LM7). The IgG fraction of the tissue culture supernatant was purified by Protein G affinity chromatography.
CD37 Monoclonal specifically detects CD37 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.Specifications
CD37 | |
Monoclonal | |
LYOPH | |
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
Q96LM7 | |
CD37 | |
Mouse myeloma cell line NS0-derived recombinant human CD37 Accession # Q96LM7 | |
100 μg | |
Primary | |
Detects human CD37. Stains human CD37 transfectants but not irrelevant transfectants. | |
Human | |
Purified |
Flow Cytometry, CyTOF | |
424925 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD37, CD37 antigentetraspanin-26, CD37 molecule, cell differentiation antigen 37, GP52-40, leukocyte antigen CD37, MGC120234, Tetraspanin-26, Tspan-26, TSPAN26, TSPAN26leukocyte surface antigen CD37 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
951 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.